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Abstract
Transplantation of bone marrow derived mesenchymal stromal cells (MSC) or olfactory ensheathing cells (OEC) have
demonstrated beneficial effects after spinal cord injury (SCI), providing tissue protection and improving the functional
recovery. However, the changes induced by these cells after their transplantation into the injured spinal cord remain largely
unknown. We analyzed the changes in the spinal cord transcriptome after a contusion injury and MSC or OEC
transplantation. The cells were injected immediately or 7 days after the injury. The mRNA of the spinal cord injured segment
was extracted and analyzed by microarray at 2 and 7 days after cell grafting. The gene profiles were analyzed by clustering
and functional enrichment analysis based on the Gene Ontology database. We found that both MSC and OEC transplanted
acutely after injury induce an early up-regulation of genes related to tissue protection and regeneration. In contrast, cells
transplanted at 7 days after injury down-regulate genes related to tissue regeneration. The most important change after
MSC or OEC transplant was a marked increase in expression of genes associated with foreign body response and adaptive
immune response. These data suggest a regulatory effect of MSC and OEC transplantation after SCI regarding tissue repair
processes, but a fast rejection response to the grafted cells. Our results provide an initial step to determine the mechanisms
of action and to optimize cell therapy for SCI.
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Introduction
Spinal cord injury (SCI) leads to partial or complete loss of
motor, sensory and autonomic functions and secondary impair-
ments below the injury level, due to damage to the local circuitry
of the spinal cord and the interruption of ascending and
descending neural pathways. SCI results in a sequence of
coordinated changes in gene and protein expression profile
associated with physiopathological events, including hemorrhage,
inflammatory and immune activation, excitotoxicity, oxidative
stress, and neuronal activity imbalances [1,2,3,4,5].
Cell therapy has become a promising approach for repairing the
injured spinal cord [6,7,8,9,10]. Several pre-clinical studies have
demonstrated that transplantation of mesenchymal stromal cells
(MSC) [11,12,13,14,15] or olfactory ensheathing cells (OEC)
[16,17,18,19,20,21] reduces tissue damage and improves func-
tional outcomes in different models of SCI, although other studies
failed to replicate such beneficial results [22,23,24,25,26]. Little is
known about the mechanisms underlying the potential benefits
after cell grafting into the injured spinal cord. Regarding the MSC
it has been suggested that the effects are due to their capability to
secrete and/or induce the expression of protective molecules such
as BDNF and GDNF [12,15], to modulate inflammation [27,28]
and to generate a more permissive environment for axonal
regeneration and neural tissue reconstruction [12,13,29,30]. The
beneficial actions of OEC include the ability of these cells to
modulate and interact with reactive astrocytes [31,32], to induce
neoangiogenesis [33,34], to remyelinate naked axons [35], to
modulate the immune response [31,33,34] and to promote axonal
regeneration [17,18,36,37].
Although a number of studies have investigated the changes in
gene expression profile after different types of SCI in laboratory
animals, no studies have focused on the analysis of gene expression
changes triggered by transplanted cells in the lesioned spinal cord.
Such information may be of importance to better understand the
cellular and molecular mechanisms modulated by the transplanted
cells. In the present work, we analyzed for the first time the gene
expression profiles of the spinal cord that received an acute or 7
days delayed graft of MSC or OEC following a contusion injury.
Our results confirm that SCI causes several changes in gene
transcription, and the injection of cells significantly modifies some
of the pathways affected after injury. Transplantation of both
MSC and OEC leads to over expression of genes involved in tissue
repair during the acute phase of the injury, and the decline during
subacute time. Our results further indicate how these cells
contribute to regulating the wound repair response after SCI,
and could explain the beneficial effects provided by the
transplantation. On the other hand, a large number of genes
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associated with the immune response were also found up-
regulated, indicative of cell rejection.
Materials and Methods
Primary Cell Cultures
Primary cultures of MSC and OEC were set up from P22 male
Sprague-Dawley rats. The animals were euthanized with CO2.
MSC culture and characterization. Tibias and femurs
were placed on cool phosphate buffered saline (PBS) and the
epiphyses were removed. The diaphyses of the bones were flushed
with PBS using a syringe and the marrow was homogenized. The
extract was filtered through a 70 mm nylon mesh and recovered by
centrifugation for 10 min at 1500 rpm. The pellet was resus-
pended in growth medium: a-MEM with L-glutamine (Life
Technologies, Grand Island, NY, USA) supplemented with 20%
heat-inactivated fetal bovine serum (FBS) (Lonza, Verviers,
Belgium), 2 mM L-glutamine (Life Technologies) and 100 units/
ml penicillin-streptomycin (Life Technologies, 100x); then plated
in 100 mm culture dishes (Iwaki, Asahi Technoglass, Chiba,
Japan) at a density of 5?106 cells/cm2. After 24 h, the supernatant
containing non-adherent cells was removed and fresh medium was
added. When the culture was near confluence, every 4–5 days, the
cells were detached using PBS with 0.05% trypsin (Life
Technologies) and 0.04% EDTA (Sigma, St. Louis, MO) and
re-plated at 5,000 cells/cm2. Cells were passaged 3–4 times and
expanded to 80–90% of confluence. The cultured MSC were
characterized by their expression of CD90 and CD29 (about 98%
of the cells in the culture expressed these markers) but not of
CD11b and CD45 surface markers (expressed by less than 1% of
the cells), and by their differentiation capability to adipocytes and
osteoblasts using methods previously described [38]. For analysis
of adipogenesis, cells were fixed for 20 min with 4% paraformal-
dehyde in phosphate buffer (PB); the adipocytes were labeled using
60% Oil red O stock solution (0.5% Oil red O in isopropanol,
Sigma) for 15 min and washed with distilled water. For osteocytes
labeling, cells were fixed using 70% ethanol pre-cooled for 1 h at
4uC, washed and incubated during 30 min with 0.1 mg/ml
Alizarin red solution (Sigma) in distilled water.
OEC culture and characterization. Olfactory bulbs were
aseptically removed and stored in cold Hank’s balanced salt
solution (HBBS) with calcium and magnesium. The meningeal
layer was stripped off with fine forceps, and the tissue was
enzymatically (trypsin 0.25%, collagenase A 1 mg/ml, and DNAse
I 1 mg/ml) and mechanically dissociated. The cells were
recovered by centrifugation in Dulbecco’s minimum essential
medium nutrient mixture F-12 Ham (DMEM) and seeded onto
25 cm2 flasks coated with poly-L-lysine and incubated in 5% CO2
at 37uC. Culture medium was DMEM supplemented with 10%
FBS (Life Technologies). Cells were kept in culture for at least 7
days. For purification, the cells were incubated with mouse anti-
p75NGFR antibody (1:100, Chemicon, MAB365), then immuno-
purified with goat anti-mouse IgG microbeads (Miltenyi Biotec)
using MACS separation (Miltenyi Biotec). The OEC culture
purity was at least 75%. For immunocytochemistry OEC cultures
were fixed with 4% paraformaldehyde in PBS for 30 minutes, then
incubated for 24 h with primary antibodies anti-p75NGFR and
anti-S100 (1:200, DiaSorin), and after washing incubated 1 h with
secondary antibodies Cy3-conjugated donkey anti-mouse (1:200,
Jackson Immunoresearch) or Alexa 488 donkey anti-mouse (1:200,
Invitrogen).
Cell Labeling
For identification after grafting, both cell types were transfected
with a lentiviral vector encoding for green fluorescent protein
(GFP) under EF1a promoter. MSC in passage 2 were plated at
2000 cells/cm2 and incubated with lentiviruses at MOI of 10
during 48 h. Then, the medium was changed and the cells
cultured as described above. OEC transduction was done at 2–3
days of selection using the same lentiviruses at MOI of 50 for 24
hours. Then, the medium was replaced by complete culture
medium and the cells cultured for 5 more days. Around 96% of
transfection efficacy was determined by GFP+ cell counting for
both MSC and OEC.
Spinal Cord Injury and Cell Transplantation
Adult Sprague-Dawley female rats (9 weeks old; 250–300 g)
were used. The animals were housed with free access to food and
water at room temperature of 2262uC. The experimental
procedures were approved by the ethical committee of the
Universitat Auto`noma de Barcelona (Procedure Number: 1169)
in accordance with the European Directive 86/609/EEC.
Under anesthesia with ketamine (90 mg/kg) and xylacine
(10 mg/kg) and aseptic conditions, a longitudinal dorsal incision
was made to expose T6–T10 spinous processes. After laminectomy
of T8–T9 vertebra, the spinal cord was subjected to a contusion of
200 Kdyns using the Infinite Horizon Impactor (Precision System
and Instrumentation, Kentucky, USA). The animals for the
transcriptome study were divided in 6 groups. Three groups of rats
were transplanted acutely, 30 min after operation (0 dpo), with
vehicle (VE 0, n = 8), with MSC (MSC 0, n = 8) or with OEC
(OEC 0, n = 8). Other three groups of rats were transplanted at 7
days post-lesion with vehicle (VE 7, n = 8), MSC (MSC 7, n = 8) or
OEC (OEC 7, n = 8). For assessment of cell localization after
grafting, GFP+ cells (gMSC or gOEC) were transplanted either
acutely or 7 days post-lesion in the corresponding groups gMSC 0
(n = 3), gOEC 0 (n = 3), gMSC 7 (n = 3) and gOEC 7 (n = 3). For
transplantation, cells were suspended in L15 medium (Life
Technologies) at 50,000 cells/ml and maintained in ice during
the time of surgery. Using a glass needle (100 mm internal
diameter, Eppendorf, Hamburg, Germany) coupled to a 10 ml
Hamilton syringe (Hamilton #701, Hamilton Co, Reno, NV,
USA), 3 ml of the corresponding cell suspension or vehicle (L15)
were intraspinally injected at the epicenter and at 2 mm rostrally
and caudally, for a total of 450,000 cells per rat. Injections were
made at a perfusion speed of 2 ml/min controlled by an automatic
injector (KDS 310 Plus, Kd Scientific, Holliston, MA, USA), and
the tip of the needle was maintained inside the cord tissue 3 min
after each injection to avoid liquid reflux. The wound was sutured
and the animals allowed to recover in a warm environment.
Bladders were expressed twice a day until reflex voiding of the
bladder was re-established. To prevent infection, amoxicillin
(500 mg/l) was given in the drinking water for one week.
Sample Preparation
The rats for the transcriptome study in each experimental group
were sacrificed randomly at 2 (n = 4) or 7 (n = 4) days post cell
injection (dpi). The groups were identified according to the code
transplant day.day_of sacrifice_post-treatment. For example, the group of
animals transplanted with MSC at 7 days post-lesion and
sacrificed 2 days after treatment was labeled as MSC 7.2. Animals
were decapitated after deep anesthesia, and a spinal cord segment
(5 mm long) centered in the contusion epicenter was harvested
and maintained in RNA-later solution (Qiagen, Barcelona, Spain).
A spinal cord segment of intact animals (n = 4) was also obtained at
the same vertebral level as for the injured animals. The samples
Transcriptome Changes in SCI by MSC or OEC Graft
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were processed for mRNA analysis following the manufacturer
instructions. The total RNA of each sample was extracted with
RNeasy mini kit (Qiagen), including a DNase step (RNase free
DNase set, Qiagen).
For cell tracking, animals injected with gMSC or gOEC were
sacrificed at 7 days post-injection. The rats were deeply
anesthetized (pentobarbital 60 mg/kg i.p.) and intracardially
perfused with 4% paraformaldehyde in PBS. The spinal cord
segment from 1 cm rostral to 1 cm caudal of the injury epicenter
(2 cm total length) was harvested and post-fixed in the same
fixative solution for 24 h and cryopreserved in 30% sucrose.
Longitudinal spinal cord sections 30 mm thick were cut with a
cryotome (Leica CM190, Leica Microsystems, Wetzlar, Germany)
and distributed in 12 series of 8 sections (separated by 360 mm)
each.
Immunohistochemistry
Spinal cord sections of GFP+ cells transplanted rats were
processed for immunohistochemistry against GFP. Tissue sections
were blocked with TBS-0.3% Triton-5% fetal bovine serum and
incubated for 24 h at 4uC with the antibody rabbit anti-GFP (1/
200, Life Technologies). After washes, sections were incubated for
2 h at room temperature with secondary antibody donkey anti-
rabbit AlexaFluor 488 (1/200, Jackson Immunoresearch). Slides
were dehydrated and mounted with Citoseal 60 (Thermo Fisher
Scientific, Madrid, Spain). Images were obtained with a digital
camera (Olympus DP50) attached to the microscope (Olympus
BX51). Analysis of the area occupied by GFP+ cells was performed
using 8 spinal cord sections (separated by 360 mm between pairs)
of each animal. Images of the spinal cord injured segment were
taken at 40x with the same setting and the total section was
mounted using Photoshop software (Adobe Systems Inc.). The
microphotographs were analyzed using ImageJ software. The GFP
labeled area in each section was measured after defining a
threshold for background correction. The volume of the graft,
spared tissue, cavity and total spinal cord injured segment were
calculated using the Cavalieri’s estimator of morphometric
volume. The statistical analysis was performed using one-way
ANOVA.
Microarray
The microarray hybridization and the statistical processing of
raw data were performed by a specialized service (Scientific and
Technical Support Unit and Statistics and Bioinformatics Unit,
Vall d’Hebron Research Institute, Barcelona, Spain). For the gene
expression an Affymetrix RAT Exon/Gene 1.1 ST chip array was
used according to the manufacturer protocol, analyzing each
animal individually as biological replicates of four animals per
experimental condition. The array data are available in Gene
Expression Omnibus database (GEO, National Centre of
Biotechnology Information), accession number GSE46988.
Data analysis. The images of hybridized microarrays were
processed with the Expression Console software (Affymetrix). Raw
expression values obtained directly from.CEL files were pre-
processed using the RMA method [39], a three-step process that
integrates background correction, normalization and filtering of
probes values. Data were first submitted to non-specific filtering to
remove low signal genes (those genes whose mean signal in each
group did not exceed a minimum threshold) and low variability
genes (those genes whose standard deviation between all samples
did not exceed a minimum threshold). The selection of differen-
tially expressed genes between conditions was based on a linear
model analysis with empirical Bayes moderation of the variance
estimated following the methodology developed by Smyth [40]
and implemented in the limma Bioconductor package. To
determine the main effects of the injury, the gene expression
profile of each injured group was compared to non injured animals
and cut-off P value ,0.05 and fold change (FC) .1.5 were applied
to select the differentially expressed genes. To determine the gene
expression changes after cell transplantation, each gene expression
profile of MSC or OEC groups was compared to the correspon-
dent vehicle group. In this case, the cut-off for differentially
expressed genes were a P value ,0.05 and a FC .1.4.
All the statistical analyses were done using the free statistical
language R and the libraries developed for microarray data
analysis by the Bioconductor Project (www.bioconductor.org).
Microarray Validation
To validate the results obtained by microarray analysis, in silico
comparison of the SCI differential expressed genes lists and RT-
PCR of target genes were performed.
In silico validation. Three different data profiles were
selected in the GEO database: GSE464 (spinal cord injury
contusion and regeneration time course in rats: above T9 (RG-
U34A)), GSE5296 (spinal cord injury contusion model in mice:
time course), and GSE22161 (comparative gene expression
analysis of thoracic spinal cord from G93A SOD1 mutant rats
and from wild type littermates following mild compression injury).
For the comparison of the GEO profile with our results, up-
regulated and down-regulated lists of genes were obtained from
the GEO data analysis tools, filtered with our microarray profile to
eliminate the probes not assessed in our chip, and compared with
the corresponding up-regulated and down-regulated lists that we
obtained from our samples. The percentages of concordant and
discordant genes with respect to the total changed genes in the
GEO data up-regulated and down-regulated profiles were
calculated. Thus, if one gene appeared up-regulated at the same
time in the GSE464 and in our results this gene contributed to the
percentage of concordance. Genes that were not coincident in the
compared list contributed to the percentage of discordance, in
which we distinguished the genes that changed in the GEO profile
but not in our data and the genes that changed in opposite
direction than in our results.
RT-PCR. 1 mg RNA of each sample was reverse-transcribed
using 10 mmol/L DTT, 200 U M-MuLV reverse transcriptase
(New England BioLabs, Barcelona, Spain), 10 U RNase Out
Ribonuclease Inhibitor (Invitrogen), 1 mmol/L oligo(dT) and
1 mmol/L of random hexamers (BioLabs, Beverly, MA, USA).
The reverse transcription cycle conditions were 25uC for 10 min,
42uC for 1 h and 72uC for 10 min. We analyzed the mRNA
expression by means of specific primer sets (Table S1). Glyceral-
dehyde 3-phosphate dehydrogenase (GADPH) expression was
used to normalize the expression levels of the different genes of
interest. Gene-specific mRNA analysis was performed by SYBR-
green PCR using the MyiQ5 PCR detection system (Bio-Rad
Laboratories, Barcelona, Spain). We previously fixed the optimal
concentration of the cDNA to be used as template for each gene
analysis to obtain reliable CT (threshold cycle) values for
quantification. Four samples were used per condition and each
one was run in duplicate. The thermal cycling conditions
comprised 3 min polymerase activation at 95uC, 40 cycles of
10 s at 95uC for denaturation and 30 s at 62uC for annealing and
extension, followed by a DNA melting curve for determination of
amplification specificity. CT values were obtained and analyzed
using BioRad Software. Fold change in gene expression was
estimated using the CT comparative method (22DDCT) normaliz-
ing to GADPH CT values and relative between pairs of samples.
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Cluster Analyses
Hierarchical cluster analyses were performed using the algo-
rithms for complete linkage and correlation (uncentered) similarity
metrics in the software Cluster 3.0 and visualized using TreeView,
both developed by Eisen et al. (1998) [41]. To determine the
similarity of the experimental conditions, an array hierarchical
clustering of the transplanted groups (MSC 0.2, MSC 0.7, MSC
7.2, MSC 7.7, OEC 0.2, OEC 0.7, OEC 7.2, OEC 7.7) was
performed. To compare the differentially expressed profiles
between MSC (MSC vs. VHC) and OEC (OEC vs. VHC), a
gene hierarchical clustering was performed for each experimental
condition. In this analysis a specific list of genes were selected from
the resulted clusters using the criteria: genes exclusively up- or
down-regulated in MSC or OEC transplanted animals and genes
that were up- or down-regulated in both cell injected group.
Analysis of Biological Meaning
To investigate the biological meaning, term enrichment analysis
in the Gene Ontology (GO, http://www.geneontology.org/) and
functional annotation GO term clustering analysis were performed
[42] for each list of genes selected in the hierarchical clustering.
The Database for Annotation, Visualization and Integrated
Discovery (DAVID, v6.7) (National Institute of Allergy and
Infectious Diseases (NIAID); http://david.abcc.ncifcrf.gov/home.
jsp) was used for DAVID’s GO biological process (GOTERM_B-
P_ALL). The GO terms were classified by functional annotation
clustering analysis, where the list of selected genes (the sample)
were compared to a reference set (the whole probes in the
Affymetrix chip used) with the following options: similarity term
overlap = 3; similarity threshold = 0.5; initial group member-
ship = 2; final group membership = 2; multiple linkage thresh-
old = 0.05; EASE = 0.05. The functional annotation clusters were
ranked from largest to smallest enrichment score (ES) and the GO
terms associated to every cluster were ranked from smallest to
largest P value. Moreover, every cluster was labeled with a
representative name of the GO terms included in the cluster.
Data Presentation
A summary of the array analysis is presented including heat
maps of array and gene hierarchical clustering, a summary of GO
functional clusters for each selected cluster and the number of up-
and down-regulated genes. The whole information of the
functional annotation cluster classification, with the GO terms
included in each cluster, the number of genes in every enriched
GO term (G) and the p value of the clustering, is also presented in
Tables S2–S20.
Results
Cell Localization in the Injured Spinal Cord
In order to assess the presence of the grafted cells after
transplantation we labeled MSC and OEC with GFP. The GFP+
cells were localized into the injured spinal cord 7 days after acute
and delayed transplantation (Fig. 1A,B). The quantification of the
GFP signal volume revealed no statistical differences between any
groups of cell transplantation (Fig. 1C).
Microarray Validation
Microarray data were validated by both in silico and RT-PCR
quantitative analyses. For the in silico comparison, the transcrip-
tional profile of the SCI samples was contrasted with three
microarrays data published in the GEO database: GSE464,
GSE5296 and GSE22161. After filtering genes that were
differentially expressed, we found that the genes that were up-
regulated and down-regulated in our experiments were very
similar to those found in a dataset obtained from rat spinal cord
following a mild contusion injury (GSE464 profile) (Fig. S1A).
Indeed, coincidence of genes that were up-regulated and down-
regulated was 88.5% and 79.1%, respectively, at day 2, and 90.8%
and 75.3%, respectively, at day 7 post-injury. Our results were also
analogous to those obtained after mild spinal cord contusion in
mice (GSE5296 profile) since the matching of genes that were up-
regulated and down-regulated at day 7 post-injury was 79.4% and
84.1%, respectively. On the other hand, less than 50% of the genes
(37.6% and 45% for up- and down-regulated genes, respectively)
coincided with the gene expression profile obtained 7 days after
spinal cord compression injury (GSE22161 profile). Therefore,
these comparisons indicate that transcriptome changes that occur
in the spinal cord are largely dependent on the type of primary
lesion.
To validate the gene expression changes observed in the rat
spinal cord after contusion, we analyzed by RT-PCR 9 targeted
genes identified in the microarray (see Table S1). The expression
changes of these 9 genes were compared between the microarray
and the RT-PCR results for each experimental group included in
the study (Fig. S1B). The results showed a significant correlation
comparing both methods (Pearson’s r = 0.87, p,0.0001), evidenc-
ing the reliability of our microarray data.
Biological Changes after Acute Cell Transplantation
Acute cell transplantation induced changes in the transcriptome
profile of the injured spinal cord. At 2 days after treatment 306
genes were found changed in comparison with vehicle injection.
Of them, 72 genes were up- and 22 down-regulated exclusively by
the MSC graft, 65 genes were up- and 84 genes down-regulated
exclusively by the OEC graft, whereas 58 and 5 genes were
observed up- and down-regulated, respectively, in both MSC and
OEC groups (Fig. 2A). The functional annotation clusters
associated with the different genes are summarized in Figure 2A
(full information in Tables S3–S10).
At 7 days after acute transplantation we found a lower number
of genes that changed their expression in comparison to results at 2
days (209 vs. 306). The MSC graft induced exclusive up-regulation
of 76 and down-regulation of 43 genes. The OEC graft induced
exclusive up-regulation of 29 and down-regulation of 12 genes.
Both cell grafts were associated with 33 up-regulated genes and 16
down-regulated genes (Fig. 2B). The functional annotation clusters
associated with the different genes are summarized in Figure 2B
(full information in Table S11–S20).
Biological Changes after Delayed Cell Transplantation
At 2 days after delayed cell transplantation, 190 genes changed
their expression by a cell graft compared with vehicle injection. 25
of these genes were up- and 99 were down-regulated exclusively by
MSC, while 30 genes were up- and 10 down-regulated only by
OEC. Both treatments up-regulated the same 9 genes and down-
regulated the same 17 genes (Fig. 3A).
At 7 days after delayed cell transplantation the expression of 308
genes was changed in comparison with vehicle injection. 42 of
these genes were up- and 132 were down-regulated exclusively by
MSC, and 21 genes were up- and 35 genes were down-regulated
exclusively by OEC. Both cell transplants up-regulated the same
33 genes and down-regulated other 15 genes (Fig. 3B). The list of
functional annotation clusters associated with genes up- or down-
regulated by each cell transplant or by both are detailed in
Figure 3A and B.
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Shared Gene Expression Changes by Cell Transplantation
The hierarchical clustering of the arrays performed between the
8 cell therapy experimental conditions revealed two profile
similarities (Fig. 4). The first level of clustering grouped the 4
groups of acute transplant in one cluster and the delayed
transplant groups in another cluster (C1 and C2 in Fig. 4). Within
these two clusters, the profiles found at early time (2 days) after
injection of MSC and OEC were clustered together (C1.1 and
C2.1 in Fig. 4), and the profiles of later time (7 days) after injection
of both types of cells were in the same cluster (C1.2 and C2.2 in
Fig. 4). These results indicate that the pattern of gene changes
induced by cell transplant is more similar between MSC and OEC
than the temporal changes triggered by the same transplanted
cells. The shared processes are mainly related to tissue repair, such
as extracellular matrix (ECM) organization, organ development,
response to wounding and cell adhesion. In addition, the immune
response events appear modulated by both cells.
ECM Organization after Cell Transplantation
ECM modulation is one of the processes shared by MSC and
OEC transplants that include some of the most changed genes in
the array, suggesting that ECM remodeling is an important
mechanism modified by cell transplantation. Figure 5 shows some
of the genes related to ECM organization that most changed their
expression. These changes involved an early up-regulation of the
matrix metalloproteases Mmp13, Mmp12, Mmp9 and Mmp8
(Fig. 5A), pro-collagen type I Col1a1 and Col1a2, Plod2, other
member of the collagen family, such as Col8a1 (Fig. 5B), and genes
involved in ECM formation, Lox (lysyl oxidase), the enzyme
responsible to link collagen with elastin, and Postn (periostin)
(Fig. 5C). While some genes showed similar temporal expression
between MSC and OEC transplants, including Mmp13, Mmp8,
Col1a1, Col1a2 and Plod2, other genes had a different temporal
pattern. The Mmp12 expression was increased only by MSC acute
transplantation. Other differences between cell grafts were
observed in Mmp9 and Postn expression after the delayed
treatment. All together these observations indicate an important
alteration of the ECM remodeling process after transplantation of
both types of cells.
Immune Response Against the Grafted Cells
Most of the GO terms clustered in the immune response
functional group were related to leukocyte migration, lymphocyte
activation, response to other organism, adaptive immune response
and antigen presentation (Tables S6, S11, S15, S16, S17).
Associated with these processes we found significant up-regulation
of CD8a and CD4 after acute OEC transplant, but only of CD4
after acute MSC transplant (Fig. 6A). A differential pattern of
expression over time was also observed for the Cxcl9 gene (Fig. 6B),
that was up-regulated after an acute OEC graft and after a delayed
MSC graft. Both acute transplants induced up-regulation of
Cxcl13, but only the delayed transplant of MSC induced its
overexpression. RT1-Da, RT1-EC2, CD74 (Fig. 6C) and C3
(Fig. 6D) showed similar temporal expression patterns, although
with some significant differences between cell grafts. In general,
the four genes increased expression from 2 to 7 days after cell
grafting. However, a stronger up-regulation of the four genes was
observed by delayed grafting of MSC than of OEC. These data
probably reflect an immune response triggered against the grafted
cells.
Specific Changes Induced by Transplanted Cells
Besides the numerous similarities between gene profiles found
after both MSC and OEC grafts in the SCI, each type of cells
specifically modulated other biological events. Thus, during the
acute phase of SCI the presence of MSC induced an early
enhancement of genes related to response to nutrient, vitamins
and external stimulus (Fig. 2A). Within these processes Wnt5a and
Ptgs2 were the most up-regulated genes (Fig. 7A). At 7 days after
acute MSC transplant Wnt5a and Ptgs2 returned to normal
expression and the negative regulation of apoptosis increased
(Fig. 2B). The most important gene associated to this process was
Sost (Sclerostin) (Fig. 7A). In the case of OEC transplants, a large
increase of catabolic and protein metabolic processes was observed
early after acute injection (Fig. 2A), with a particular up-regulation
of Nos2 gene (Fig. 7B). At 7 days after acute OEC transplant,
genes modulated by OEC were related to tissue repair.
After delayed transplantation, MSC induced a decreased
expression of genes related to external stimulus and vitamin and
nutrient levels response at both time post-grafting (Fig. 3A and B),
and among them Alpl and Fabp4 were the most down-regulated
genes (Fig. 7C). For OEC delayed transplantation, besides genes
related to tissue repair, the genes involved in the response to
external stimulus were potentiated at the early time after treatment
(Fig. 3A), being Irf7 the most relevant gene in this functional group
(Fig. 7D).
Figure 1. Grafted cell survival in the injured spinal cord. GFP labeled MSC and OEC were transplanted into the spinal cord after contusion at
acute or delayed time. At 7 days post injection (dpi), both OEC (A) and MSC (B) were localized in the spinal cord parenchyma (delimited by dotted
lines), surrounding the injection points (arrows). The volume quantification of the GFP signal showed no significant differences between groups (C).
Scale bar = 2000 mm.
doi:10.1371/journal.pone.0076141.g001
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Figure 2. Changes in gene expression after acute MSC and OEC transplantation. The figure shows the gene profiles comparison between
MSC and OEC at 2 (A) and 7 (B) days after acute transplantation in rats with a spinal cord contusion. Each panel contains the Venn diagram (top left)
showing the number of differentially expressed genes (in red, up-regulated genes; in green, down-regulated genes), the heat map of the
corresponding hierarchical clustering with the clusters trees, and the summary tables of the functional annotation analysis results. In the heat map
the columns represent the mean of four animals analyzed per group.
doi:10.1371/journal.pone.0076141.g002
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Figure 3. Changes in gene expression after delayed MSC and OEC transplantation. The figure shows the gene profiles comparison
between MSC and OEC at 2 (A) and 7 (B) days after one week delayed transplantation in rats with a spinal cord contusion. Each panel contains the
Venn diagram (top left) showing the number of differentially expressed genes (in red, up-regulated genes; in green, down-regulated genes), the heat
map of the corresponding hierarchical clustering with the clusters trees, and the summary tables of the functional annotation analysis results. In the
heat map the columns represent the mean of four animals analyzed per group.
doi:10.1371/journal.pone.0076141.g003
Transcriptome Changes in SCI by MSC or OEC Graft
PLOS ONE | www.plosone.org 7 October 2013 | Volume 8 | Issue 10 | e76141
Discussion
Several studies have shown that transplantation of MSC and of
OEC after SCI exert beneficial effects on functional recovery,
tissue protection, axonal regeneration and remyelination. Howev-
er, the mechanisms and changes triggered by the grafted cells on
the spinal cord are still poorly understood. The results of the
present study contribute to the knowledge of the role played by
MSC and OEC transplants in the injured spinal cord, and provide
important information regarding the genes and pathways modified
by these cells when grafted into the injured spinal cord.
Cell Therapy and Tissue Healing
Endogenous repair or wound healing processes are activated
quickly, synchronically and sequentially after tissue damage in
order to avoid the expansion of the injury and to provide a suitable
environment for tissue regeneration [43,44]. The repair dynamic
events include: blood clotting and fibrin formation, recruitment of
inflammatory cells, angiogenesis, ECM synthesis and collagen
deposition, and cell proliferation [43,44]. All these events have to
be precisely regulated, otherwise they can induce undesirable
effects in the damaged tissue, such as cyst formation, tissue fibrosis
and prevention of regenerative mechanisms [44]. Chronification
of the wound healing process occurs after injuries to the CNS, and
thus, therapies aimed at inducing the remission of these events are
expected to induce neuroprotection and a better milieu for axonal
regeneration. The results showed herein suggest that both MSC
and OEC can promote different aspects of tissue repair
mechanisms, which may explain, in part, the beneficial effects of
their grafting after injury.
Our microarray data showed that acute transplantation of both
cell types induced early gene expression related to regulation of
cell adhesion, hemopoiesis, response to hypoxia, organ develop-
ment and ECM organization. These changes demonstrate shared
mechanisms of MSC and OEC transplants, probably by
increasing some aspects of the wound response. However, other
genes associated to ECM organization, blood vessel development,
cell adhesion and response to wounding and tissue development
were up-regulated only by acute MSC transplant at early times,
indicative that the changes in these processes were more important
after MSC than OEC acute injection. On the other hand, when
MSC and OEC were transplanted in subacute SCI, most of the
effects induced by both cell grafts were related to the suppression
of biological events, especially, mechanisms related to tissue repair.
Nevertheless, the enriched pathways shared by both cells were
limited since those related to tissue repair were decreased
specifically by MSC or OEC treatment. Thus, a reduction of
organ development, response to nutrient levels, blood vessel
development and ECM organization events were observed during
the early time by MSC, whereas blood vessel development and
ECM organization were suppressed only by OEC at later time.
Therefore, MSC or OEC transplantation may induce changes in
mechanisms of tissue repair by both common and specific events
and in a complex temporal pattern. Moreover, these changes seem
to be more important after MSC transplant, probably because
their role during tissue repair [45,46,47].
ECM remodeling after cell transplantation. As previously
mentioned, cell therapy induced changes in genes related to ECM
organization, which is necessary for effective tissue repair [43,44].
Both acute MSC and OEC grafts enhanced the expression of
genes related to ECM organization and collagen synthesis, in
particular those related with collagen I deposition, such as the
genes coding for collagen type I (Col1a1 and Col1a2), and
collagen type VIII (Col8a1), Plod2 (procollagen-lysine, 2-oxoglu-
tarate 5-dioxygenase 2), a lysyl hydroxylase enzyme that influences
the stability of intermolecular collagen cross-links [48], and the
matrix metalloproteases Mmp13, Mmp12, Mmp8 and Mmp9.
Fibril collagen deposition, specially of collagen type I and III, is
essential during the early phase of tissue repair and wound healing
[43], forming the base of the new ECM that replaces the fibrin clot
and allows the regeneration of the tissue. After SCI, collagen I
increases and is distributed around blood vessels forming a scaffold
for angiogenesis [49]. The beneficial effects of both MSC [15] and
OEC [33] have been related with the formation of new blood
vessels. In fact, the results of the microarray showed an enrichment
of blood vessel development events after acute MSC transplanta-
tion. Furthermore, collagen type VIII is related with vascular
smooth muscle cells, promoting their migration and growth [50].
In addition, Plod2 is involved in the collagen fibril deposition [48]
and its expression is increased in response to hypoxia [51]. Matrix
metalloproteases also play an important role during tissue repair
participating in matrix degradation to allow debriding, ECM
restyling, and cell migration. Mmp13, also known as collagenase-
3, is involved in angiogenesis during tissue repair [52] and in the
vascularization of tumors [53]. Moreover, it was recently
demonstrated that Mmp13 is essential for granulated tissue
formation in wound healing [54]. In the CNS, Mmp13 expression
is induced in astrocytes by hypoxia signaling and increases the
permeability of the blood-brain-barrier [55]. Thus, Mmp13 and
other matrix metalloproteases play an important role in vascular
physiology regulation [56]. Other important protein in the ECM
remodeling that we found up-regulated after acute transplants is
Postn (periostin). Periostin is an ECM protein that interacts with
other matrix components, such as collagen I [57]. Their
Figure 4. Hierarchical clustering of the array. The experimental
conditions were submitted to hierarchical clustering and the corre-
sponding heat map and cluster tree are shown. The clustering analysis
determines a classification in two big clusters including the acute (C1)
and delayed transplant (C2). In these two clusters the MSC and the OEC
induced profile at 2 days (C1.1 and C2.1) and at 7 days (C1.2 and C2.2)
after acute or delayed treatment were grouped.
doi:10.1371/journal.pone.0076141.g004
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interaction allows the activation of LOX (lysyl oxidase) [57], an
enzyme responsible for cross-linking other proteins with collagen.
It is important to note that the overexpression of most of the above
mentioned genes was higher after MSC than OEC transplant,
probably indicating stronger effects of the MSC on ECM
remodeling.
Regarding delayed transplants, the genes related to collagen
type I and Plod2 were not changed, whereas the expression of
Col8a1 and Lox were reduced by both cell treatments, although
with temporal differences. Genes coding for matrix metallopro-
teases, such as Mmp12, Mmp8 and Mmp9, were reduced by MSC
grafting and increased by OEC grafting, reflecting different
regulatory mechanisms of the ECM between MSC and OEC. All
together, the regulation of ECM remodeling seems to be achieved
by mechanisms shared by both MSC and OEC during the acute
phase after SCI, while delayed injection of the cells induces
different genetic changes. Furthermore, most of the ECM related
genes modulated by the cells are involved in vascular physiology
and angiogenesis suggesting a role of transplanted cells in
revascularization of the damaged tissue.
MSC and tissue repair. Our data suggest a regulatory role
for MSC when transplanted into the injured spinal cord, boosting
the restorative mechanisms at early phases following SCI but
inducing resolution at later time points and accelerating the
homeostasis of the injured tissue. The potentiation of repair
processes could be the most probable mechanism underlying the
beneficial effects of the MSC transplantation after SCI regarding
tissue sparing [12,15,29,52], neoangiogenesis [15] and inflamma-
tory modulation [27,28]. In vivo, MSC enhance the regenerative
potential of different tissues as a result of paracrine mechanisms
that become activated when the cells are exposed to an injury
environment [45,46,47,58,59]. During the inflammation phase of
wound healing, proinflammatory mediators can activate regula-
tory functions in MSC, leading to secretion of inflammatory
mediators [60] and anti-inflammatory cytokines [61]. As a result,
the activity of MSC in the injured tissues potentiates wound
Figure 5. ECM related genes. Graphical representation of genes related to ECM remodeling, such as matrix metalloproteases (A), collagen
associated genes (B) and other genes related to collagen interaction proteins (C). Each graph shows the fold changes of the corresponding gene after
acute (2 and 7 days post injury) and delayed (9 and 14 days post injury) cell transplantation in comparison to vehicle values. Data are represented as
mean 6 SEM. $ p,0.05 OEC vs. vehicle, & p,0.05 MSC vs. vehicle.
doi:10.1371/journal.pone.0076141.g005
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healing and tissue regeneration [62,63]. During the proliferation
phase, paracrine factors secreted by the MSC, including bFGF,
VEGF, HGF, IL10 and MMP-9 [64,65], stimulate survival and
proliferation of resident cells [66,67], angiogenesis [68,69] and
Figure 6. Rejection response related genes. Graphical representation of some genes related to immune response, such as lymphocyte markers
(A), cytokines (B), major histocompatibility complex I and II (C) and C3, the complement component 3 (D). Each graph shows the fold changes of the
corresponding gene after acute (2 and 7 days post injury) and delayed (9 and 14 days post injury) cell transplantation in comparison to vehicle value.
Data are represented as mean 6 SEM. $ p,0.05 OEC vs. vehicle, & p,0.05 MSC vs. vehicle.
doi:10.1371/journal.pone.0076141.g006
Figure 7. Specific genes modulated by cells. Graphical representation of some genes that were specifically expressed by acute MSC (A), acute
OEC (B), delayed MSC (C) or delayed OEC (D) transplantations. Each graph shows the fold changes of the corresponding gene after acute (2 and 7
days post injury) and delayed (9 and 14 days post injury) cell transplantation in comparison to vehicle value. Data are represented as mean 6 SEM. $
p,0.05 OEC vs. vehicle, & p,0.05 MSC vs. vehicle.
doi:10.1371/journal.pone.0076141.g007
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vascular stability [70]. Moreover, it has been proposed that
perivascular cells named pericytes are indeed MSC that readily
infiltrate tissues after blood vessel breakdown, acting as a cellular
sensor of damage and secreting mediators for tissue repair [45].
Pericytes have been found to play a crucial role in repair processes
after SCI [71]. This can explain, in part, the potential benefits of
the therapeutic transplantation of MSC [58,72,73].
OEC and tissue repair. As discussed above, the acute
presence of OEC in the injured spinal cord induced the expression
of genes related to tissue repair, whereas a reduction of some of
these pathways was observed after delayed transplantation. Of
interest, most of the early changes observed after acute OEC
injection were related to genes associated with inflammatory and
immune response, particularly Cxcl9 and Nos2 (inducible Nitric
oxide synthase 2 or iNos). Nos2 expression after SCI is closely
related to macrophage/microglia activation, but it is also up-
regulated in neurons, astrocytes and oligodendrocytes [74]. These
results may be related to previous data from our laboratory
describing earlier and stronger recruitment of microglia/macro-
phages by an acute OEC graft in the injured spinal cord of rats
[33]. In addition, administration of Nos2 inhibitors reduced tissue
sparing, functional outcomes and angiogenic activity of OEC
transplantation after SCI [75], suggesting a beneficial role of the
Nos2 overexpression induced by OEC. In agreement with our
results, gene expression analysis has shown that OEC express a
large range of genes involved in wound healing, ECM remodeling,
cell adhesion and angiogenesis [32]. Despite the marked early
changes in expression profile induced by acute OEC transplant
following SCI, few changes were observed at 7 days following the
acute transplantation. This could be due to rejection of the
transplanted cells in the spinal cord, as well as to poor integration
and migration but strong boundering [76,77] of the OEC in the
injured spinal cord. Delayed transplantation of OEC after SCI
induced a few changes in the gene expression profile. Among the
modulated mechanisms, we found reduced expression of tissue
repair associated genes, suggesting a modulatory capability of
OEC when transplanted in a subacute SCI.
The results showed herein suggest that the early presence of
MSC or OEC in the injured spinal cord may potentiate or
accelerate some of the tissue repair mechanisms. This could enable
a faster homeostasis recovery, enhancing ECM remodeling,
limiting expansion of the lesion and creating a favorable
environment for tissue regeneration, while at delayed times the
transplanted cells seem to reduce the tissue repair response to
inhibit chronification of the wound healing process.
Grafted Cell Rejection
One of the most remarkable results observed after acute or
delayed cell transplantation was the up-regulation of genes
involved in immune response and specifically the response against
foreign organisms. Indeed, the gene expression profile was
enriched in the cluster of processes such as immune and defense
response, leukocyte activation, chemotaxis and migration, leuko-
cyte mediated immunity, antigen processing and presentation, and
adaptive immune response. In the list of genes associated with
these processes we found an overexpression of the rat major
histocompatibility complex (MHC) class I, such as RT1-N1, RT1-
N3 and RT1-EC2, and class II, such as RT1-Da and RT1-Ba (Fig.
S2) [78,79]. The expression of these genes may indicate the
presence of antigen presenting cells (APC), presenting MHC class I
and class II antigens. The presence of MHC class I antigens
stimulates the immature CD8+ lymphocytes to become mature
cytotoxic T lymphocytes [80,81,82] that induce apoptosis in the
grafts. In our gene array we found an over expression of CD8
indicating the presence of mature or immature cytotoxic T
lymphocytes in the injured spinal cord tissue after transplantation.
In addition, the MHC class II antigen presented by APC interacts
with CD4+ immature lymphocytes inducing their maturation to
mature T-helper CD4+ lymphocytes [82]. We also found an up-
regulation of CD74, involved in the formation and transport to
membrane of MHC class II, CD4 and some chemokines that act
as chemoattractants to T-cells, such as Cxcl9 and Cxcl10 (Fig. S2)
[83,84,85], and B-cells, such as Cxcl13 [84,85], suggesting
recruitment of CD4+ T-cells and B-cells. Collectively, these results
may indicate a host rejection response against the grafted cells
initiated at least at day 7 post-transplantation of MSC and OEC.
Although this event was found after both MSC and OEC
transplants, the earlier increase of CD8 and CD4 induced by acute
OEC than MSC injection and the higher overexpression of MHC
I and II after delayed MSC than OEC injection suggest a
differential rejection response.
Some published data point to limited survival of grafted cells
after spinal cord contusion. Reaction against engrafted MSC was
observed in the intact spinal cord [86,87], with an important
recruitment of macrophages, leading to a marked reduction in the
number of cells between 2 and 4 weeks after their injection in
comparison to a syngeneic transplant [86]. Furthermore, the
administration of cyclosporine A, an immunosuppressant drug,
prolongs the survival of the grafted cells [86,87], confirming the
immune rejection induced in the spinal cord. After SCI, limited
survival was also found of xenogeneic human MSC [12] and
allogeneic MSC grafted in contused rats [27,88] and of allografts
in dogs [89]. In the same way, OEC transplanted after contusion
injury in rats also had reduced survival [24]. Survival of the grafted
cells largely influences the treatment success, and thus, the
combination of cell grafts with immunosuppressant agents is
probably needed to optimize the efficacy of cell therapies.
Conclusion
Our data provide an overview of the mechanisms modulated by
MSC and OEC when transplanted after SCI. The changes
observed in gene expression profile suggest that transplantation of
both, MSC and OEC, accelerates and/or enhances tissue repair
events during the early stages of the injury, while it tends to resolve
these processes at later time points. However, the activation of the
adaptive immune response in the grafted spinal cord after
transplantation is indicative of cell rejection. Further investigations
are needed to better understand the neuroprotective actions of
MSC and OEC grafts, as well as to avoid cell rejection to optimize
cell therapies for clinical application in SCI.
Supporting Information
Figure S1 Microarray data validation. (A) In silico compar-
ison of our gene array results showed a high concordance of up-
regulated genes and down-regulated genes with results previously
published after the same type of injury in rats (GSE464) and in
mice (GSE5296), but not with another type of SCI in rats
(GSE22161). (B) The validation of some target genes by RT-PCR
indicated good concordance between expression changes obtained
by microarray and by RT-PCR (Pearson correlation, r = 0.87,
p,0.0001). In this comparison a few discrepancies were observed
but only in target genes that did not reach the cut-off of significant
changes (inside the square in B).
(TIF)
Figure S2 Rejection response related genes. Graphical
representation of RT1-N1, RT1-N3, RT1-Ba and Cxcl10 genes.
Each graph shows the fold changes of the corresponding gene after
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acute (2 and 7 days post injury) and delayed (9 and 14 days post
injury) cell transplantation in comparison to vehicle value. Data
are represented as mean 6 SEM. $ p,0.05 OEC vs. vehicle, &
p,0.05 MSC vs. vehicle.
(TIF)
Table S1 Primers used for RT-PCR and microarray
validation. RT-PCR was performed with primers of genes with
expression changed at least in one experimental condition of the
study.
(DOC)
Table S2 Functional annotation cluster: MSC 0.2 UP.
(DOC)
Table S3 Functional annotation cluster: OEC 0.2 UP.
(DOC)
Table S4 Functional annotation cluster: MSC and OEC
0.2 UP.
(DOC)
Table S5 Functional annotation cluster: MSC 0.2 Down.
(DOC)
Table S6 Functional annotation cluster: MSC 0.7 UP.
(DOC)
Table S7 Functional annotation cluster: OEC 0.7 UP.
(DOC)
Table S8 Functional annotation cluster: MSC and OEC
0.7 UP.
(DOC)
Table S9 Functional annotation cluster: MSC 0.7
DOWN.
(DOC)
Table S10 Functional annotation cluster: MSC and OEC
0.7 DOWN.
(DOC)
Table S11 Functional annotation cluster: MSC 7.2 UP.
(DOC)
Table S12 Functional annotation cluster: OEC 7.2 UP.
(DOC)
Table S13 Functional annotation cluster: MSC 7.2
DOWN.
(DOC)
Table S14 Functional annotation cluster: MSC and OEC
7.2 DOWN.
(DOC)
Table S15 Functional annotation cluster: MSC 7.7 UP.
(DOC)
Table S16 Functional annotation cluster: OEC 7.7 UP.
(DOC)
Table S17 Functional annotation cluster: MSC and OEC
7.7 UP.
(DOC)
Table S18 Functional annotation cluster: MSC 7.7
DOWN.
(DOC)
Table S19 Functional annotation cluster: OEC 7.7
DOWN.
(DOC)
Table S20 Functional annotation cluster: MSC and OEC
7.7 DOWN.
(DOC)
Acknowledgments
We thank Monica Espejo, Jessica Jaramillo and Marta Morell for technical
help.
Author Contributions
Conceived and designed the experiments: ATE JH XN. Performed the
experiments: ATE JH. Analyzed the data: ATE JH XN. Contributed
reagents/materials/analysis tools: ATE JH XN. Wrote the paper: ATE
XN.
References
1. Aimone JB, Leasure JL, Perreau VM, Thallmair M (2004) Spatial and temporal
gene expression profiling of the contused rat spinal cord. Exp. Neurol. 189: 204–
221.
2. Afjehi-Sadat L, Brejnikow M, Kang SU, Vishwanath V, Walder N, et al. (2010)
Differential protein levels and post-translational modifications in spinal cord
injury of the rat. J. Prot. Res. 9: 1591–1597.
3. Carmel JB, Galante A, Soteropoulos P, Tolias P, Recce M, et al. (2001) Gene
expression profiling of acute spinal cord injury reveals spreading inflammatory
signals and neuron loss. Physiol. Genomics 7: 201–213.
4. De Biase A, Knoblach SM, Di Giovanni S, Fan C, Molon A, et al. (2005) Gene
expression profiling of experimental traumatic spinal cord injury as a function of
distance from impact site and injury severity. Physiol. Genomics 22: 368–381.
5. Di Giovanni S, Knoblach SM, Brandoli C, Aden SA, Hoffman EP, et al. (2003)
Gene profiling in spinal cord injury shows role of cell cycle in neuronal death.
Ann. Neurol. 53: 454–468.
6. Coutts M, Keirstead HS (2008) Stem cells for the treatment of spinal cord injury.
Exp. Neurol. 209: 368–377.
7. Herna´ndez J, Torres-Espı´n A, Navarro X (2011) Adult stem cell transplants for
spinal cord injury repair: current state in preclinical research. Curr. Stem Cell
Res. Ther. 6: 273–287.
8. Mothe AJ, Tator CH (2012) Advances in stem cell therapy for spinal cord injury.
Sci. Med. 122: 3824–3834.
9. Sahni V, Kessler JA (2010) Stem cell therapies for spinal cord injury. Nat. Rev.
Neurol. 6: 363–372.
10. Tetzlaff W, Okon EB, Karimi-Abdolrezaee S, Hill CE, Sparling JS, et al. (2011)
A systematic review of cellular transplantation therapies for spinal cord injury. J.
Neurotrauma 28: 1611–1682.
11. Chopp M, Xue CA, Zhang H, Li Y, Wang L, et al. (2000) Spinal cord injury in
rat?: treatment with bone marrow stromal cell transplantation. NeuroReport 11:
3001–3005.
12. Himes BT, Neuhuber B, Coleman C, Kushner R, Swanger SA, et al. (2006)
Recovery of function following grafting of human bone marrow-derived stromal
cells into the injured spinal cord. Neurorehabil. Neural Repair. 20: 278–296.
13. Hofstetter CP, Schwarz EJ, Hess D, Widenfalk J, El Manira A, et al. (2002)
Marrow stromal cells form guiding strands in the injured spinal cord and
promote recovery. PNAS 99: 2199–2204.
14. Neuhuber B, Himes BT, Shumsky JS, Gallo G, Fischer I (2005) Axon growth
and recovery of function supported by human bone marrow stromal cells in the
injured spinal cord exhibit donor variations. Brain Res. 1035: 73–85.
15. Quertainmont R, Cantinieaux D, Botman O, Sid S, Schoenen J, et al. (2012)
Mesenchymal stem cell graft improves recovery after spinal cord injury in adult
rats through neurotrophic and pro-angiogenic actions. PloS One 7: e39500.
16. Garcı´a-Alı´as G, Lo´pez-Vales R, Fore´s J, Navarro X, Verdu´ E (2004) Acute
transplantation of olfactory ensheathing cells or Schwann cells promotes
recovery after spinal cord injury in the rat. J. Neurosci. Res. 75: 632–641.
17. Li Y, Field PM, Raisman G (1998) Regeneration of adult rat corticospinal axons
induced by transplanted olfactory ensheathing cells. J. Neurosci. 18: 10514–
10524.
18. Lo´pez-Vales R, Fore´s J, Verdu´ E, Navarro X (2006) Acute and delayed
transplantation of olfactory ensheathing cells promote partial recovery after
complete transection of the spinal cord. Neurobiol. Dis. 21: 57–68.
19. Lu J, Feron F, Mackay-Sim A, Waite PM (2002) Olfactory ensheathing cells
promote locomotor recovery after delayed transplantation into transected spinal
cord. Brain 125: 14–21.
Transcriptome Changes in SCI by MSC or OEC Graft
PLOS ONE | www.plosone.org 12 October 2013 | Volume 8 | Issue 10 | e76141
20. Ramo´n-Cueto A, Cordero MI, Santos-Benito FF, Avila J (2000) Functional
recovery of paraplegic rats and motor axon regeneration in their spinal cords by
olfactory ensheathing glia. Neuron 25: 425–435.
21. Verdu´ E, Garcı´a-Alı´as G, Fore´s J, Lo´pez-Vales R, Navarro X (2003) Olfactory
ensheathing cells transplanted in lesioned spinal cord prevent loss of spinal cord
parenchyma and promote functional recovery. Glia. 42: 275–286.
22. Barakat D, Gaglani S, Neravetla S, Sanchez A, Andrade C, et al. (2005)
Survival, integration, and axon growth support of glia transplanted into the
chronically contused spinal cord. Cell Transplant. 14: 225–240.
23. Collazos-Castro J, Mun˜eto´n-Go´mez V, Nieto-Sampedro M (2005) Olfactory glia
transplantation into cervical spinal cord contusion injuries. J. Neurosurg. Spine
3: 308–317.
24. Pearse DD, Sanchez AR, Pereira FC, Andrade CM, Puzis R, et al. (2007)
Transplantation of Schwann cells and/or olfactory ensheathing glia into the
contused spinal cord?: survival, migration, axon association and functional
recovery. Glia 55: 976–1000.
25. Steward O, Sharp K, Selvan G, Hadden A, Hofstadter M, et al. (2006) A re-
assessment of the consequences of delayed transplantation of olfactory lamina
propria following complete spinal cord transection in rats. Exp. Neurol. 198:
483–499.
26. Takami T, Oudega M, Bates ML, Wood PM, Kleitman N, et al. (2002)
Schwann cell but not olfactory ensheathing glia transplants improve hindlimb
locomotor performance in the moderately contused adult rat thoracic spinal
cord. J. Neurosci. 22: 6670–6681.
27. Abrams MB, Dominguez C, Pernold K, Reger R (2009) Multipotent
mesenchymal stromal cells attenuate chronic inflammation and injury-induced
sensitivity to mechanical stimuli in experimental spinal cord injury. Restor.
Neurol. Neurosci. 27: 307–321.
28. Nakajima H, Uchida K, Guerrero AR, Watanabe S, Sugita D, et al. (2012)
Transplantation of mesenchymal stem cells promotes an alternative pathway of
macrophage activation and functional recovery after spinal cord injury. J.
Neurotrauma 29: 1614–1625.
29. Ankeny DP, Mctigue DM, Jakeman LB (2004) Bone marrow transplants provide
tissue protection and directional guidance for axons after contusive spinal cord
injury in rats. Exp Neurol. 190: 17–31.
30. Koda M, Kamada T, Hashimoto M, Murakami M, Shirasawa H, et al. (2007)
Adenovirus vector-mediated ex vivo gene transfer of brain-derived neurotrophic
factor to bone marrow stromal cells promotes axonal regeneration after
transplantation in completely transected adult rat spinal cord. Eur. Spine J.
2206–2214.
31. Chuah MI, Hale DM, West AK (2011) Interaction of olfactory ensheathing cells
with other cell types in vitro and after transplantation: glial scars and
inflammation. Exp. Neurol. 229: 46–53.
32. Franssen EHP, De Bree FM, Verhaagen J (2007) Olfactory ensheathing glia:
their contribution to primary olfactory nervous system regeneration and their
regenerative potential following transplantation into the injured spinal cord.
Brain. Res. Rev. 56: 236–258.
33. Lo´pez-Vales R, Garcı´a-Alı´as G, Fore´s J, Navarro X, Verdu´ E (2004) Increased
expression of cyclo-oxygenase 2 and vascular endothelial growth factor in
lesioned spinal cord by transplanted olfactory ensheathing cells. J. Neurotrauma
21: 1031–1043.
34. Richter MW, Fletcher PA, Liu J, Tetzlaff W, Roskams AJ (2005) Lamina propria
and olfactory bulb ensheathing cells exhibit differential integration and
migration and promote differential axon sprouting in the lesioned spinal cord.
J. Neurosci. 25: 10700–10711.
35. Imaizumi T, Lankford KL, Waxman SG, Greer CA, Kocsis JD (1998)
Transplanted olfactory ensheathing cells remyelinate and enhance axonal
conduction in the demyelinated dorsal columns of the rat spinal cord. J.
Neurosci. 18: 6176–6185.
36. Lo´pez-Vales R, Fore´s J, Navarro X, Verdu´ E (2007) Chronic transplantation of
olfactory ensheathing cells promotes partial recovery after complete spinal cord
transection in the rat. Glia 311: 303–311.
37. Stamegna JC, Felix MS, Roux-Peyronnet J, Rossi V, Fe´ron F, et al. (2011) Nasal
OEC transplantation promotes respiratory recovery in a subchronic rat model of
cervical spinal cord contusion. Exp. Neurol. 229: 120–131.
38. Harting M, Jimenez F, Pati S, Baumgartner J, Cox C (2008) Immunophenotype
characterization of rat mesenchymal stromal cells. Cytotherapy 10: 245–253.
39. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay BD, Antonellis KJ, et al. (2004)
Exploration, normalization, and summaries of high density oligonucleotide array
probe level data. Biostatistics 4: 249–264.
40. Smyth GK (2004) Linear models and empirical bayes methods for assessing
differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol.
3: 3.
41. Eisen M, Spellman P, Brown P, Botstein D (1998) Cluster analysis and display of
genome-wide expression patterns. PNAS 95: 14863–14868.
42. Huang DW, Sherman BT, Lempicki RA (2009) Bioinformatics enrichment
tools: paths toward the comprehensive functional analysis of large gene lists.
Nucleic Acids Res. 37: 1–13.
43. Teller P, White TK (2009) The physiology of wound healing: injury through
maturation. Surg. Clin. North Am. 89: 599–610.
44. Velnar T, Bailey T, Smrkolj V (2009) The wound healing process: An overview
of the cellular and molecular mechanisms. J. Int. Med. Res. 37: 1528–1542.
45. Caplan AI (2008) All MSCs are pericytes? Cell Stem Cell 3: 229–230.
46. Caplan AI, Correa D (2011) The MSC: an injury drugstore. Cell Stem Cell 9:
11–15.
47. Valtieri M, Sorrentino A (2008) The mesenchymal stromal cell contribution to
homeostasis. J. Cell Physiol. 217: 296–300.
48. Van der Slot AJ, Zuurmond A-M, Bardoel AFJ, Wijmenga C, Pruijs HEH, et al.
(2003) Identification of PLOD2 as telopeptide lysyl hydroxylase, an important
enzyme in fibrosis. J. Biol. Chem. 278: 40967–40972.
49. Okada M, Miyamoto O, Shibuya S, Zhang X, Yamamoto T, et al. (2007)
Expression and role of type I collagen in a rat spinal cord contusion injury
model. Neurosci. Res. 58: 371–377.
50. Cherepanova OA, Pidkovka NA, Sarmento OF, Yoshida T, Adiguzel E, et al.
(2010) Oxidized phospholipids induce type VIII collagen expression and
vascular smooth muscle cell migration. Circul. Res. 104: 609–618.
51. Gilkes DM, Bajpai S, Chaturvedi P, Wirtz D, Semenza GL (2013) Hypoxia-
inducible factor 1 (HIF-1) promotes extracellular matrix remodeling under
hypoxic conditions by inducing P4HA1, P4HA2, and PLOD2 expression in
fibroblasts. J. Biol. Chem. 288: 10819–10829.
52. Kosaki N, Takaishi H, Kamekura S, Kimura T, Okada Y, et al. (2007) Impaired
bone fracture healing in matrix metalloproteinase-13 deficient mice. Biochem.
Biophys. Res. Commun. 354: 846–851.
53. Kudo Y, Iizuka S, Yoshida M, Tsunematsu T, Kondo T, et al. (2012) Matrix
metalloproteinase-13 (MMP-13) directly and indirectly promotes tumor
angiogenesis. J. Biol. Chem. 287: 38716–38728.
54. Toriseva M, Laato M, Carpe´n O, Ruohonen ST, Savontaus E, et al. (2012)
MMP-13 regulates growth of wound granulation tissue and modulates gene
expression signatures involved in inflammation, proteolysis, and cell viability.
PloS One 7: e42596.
55. Lu D-Y, Yu W-H, Yeh W-L, Tang C-H, Leung Y-M, et al. (2009) Hypoxia-
induced matrix metalloproteinase-13 expression in astrocytes enhances perme-
ability of brain endothelial cells. J. Cell. Physiol. 220: 163–173.
56. Siefert S, Sarkar R (2012) Matrix metalloproteinases in vascular physiology and
disease. Vascular 20: 210–216.
57. Kudo A (2011) Periostin in fibrillogenesis for tissue regeneration. Cell. Mol. Life
Sci. 68: 3201–3207.
58. Bieback K, Wuchter P, Besser D, Franke W, Becker M, et al. (2012)
Mesenchymal stromal cells (MSCs): science and f(r)iction. J. Molecular Med.
90: 773–782.
59. Jackson WM, Nesti LJ, Tuan RS (2012) Concise review: clinical translation of
wound healing therapies based on mesenchymal stem cells. Stem Cell Trans.
Med. 1: 44–50.
60. Ne´meth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, et al. (2009)
Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent
reprogramming of host macrophages to increase their interleukin-10 production.
Nat. Med. 15: 42–49.
61. Ren G, Zhang L, Zhao X, Xu G, Zhang Y, et al. (2008) Mesenchymal stem cell-
mediated immunosuppression occurs via concerted action of chemokines and
nitric oxide. Cell Stem Cell 2: 141–150.
62. Jeon YK, Jang YH, Yoo DR, Kim SN, Lee SK, et al. (2010) Mesenchymal stem
cells’ interaction with skin: Wound-healing effect on fibroblast cells and skin
tissue. Wound Repair Regen. 18: 655–661.
63. Peranteau WH, Zhang L, Muvarak N, Badillo AT, Radu A, et al. (2008) IL-10
overexpression decreases inflammatory mediators and promotes regenerative
healing in an adult model of scar formation. J. Invest. Dermatol. 128: 1852–
1860.
64. Chen L, Tredget EE, Wu PY, Wu Y (2008) Paracrine factors of mesenchymal
stem cells recruit macrophages and endothelial lineage cells and enhance wound
healing. PLoS One 3: e1886.
65. Kim CH, Lee JH, Won JH, Cho MK (2011) Mesenchymal stem cells improve
wound healing in vivo via early activation of matrix metalloproteinase-9 and
vascular endothelial growth factor. J. Korean Med. Sci. 26: 726–733.
66. Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, et al. (2004) Local
delivery of marrow-derived stromal cells augments collateral perfusion through
paracrine mechanisms. Circulation 109: 1543–1549.
67. Park KS, Kim YS, Kim JH, Choi B, Kim SH, et al. (2010) Trophic molecules
derived from human mesenchymal stem cells enhance survival, function, and
angiogenesis of isolated islets after transplantation. Transplantation 89: 509–517.
68. Gruber R, Kandler B, Holzmann P, Vo¨gele-Kadletz M, Losert U, et al. (2005)
Bone marrow stromal cells can provide a local environment that favors
migration and formation of tubular structures of endothelial cells. Tissue Eng.
11: 896–903.
69. Kaigler D, Krebsbach PH, Polverini PJ, Mooney DJ (2003) Role of vascular
endothelial growth factor in bone marrow stromal cell modulation of endothelial
cells. Tissue Eng. 9: 95–103.
70. Lozito TP, Taboas JM, Kuo CK, Tuan RS (2009) Mesenchymal stem cell
modification of endothelial matrix regulates their vascular differentiation. J. Cell
Biochem. 107: 706–713.
71. Go¨ritz C, Dias DO, Tomilin N, Barbacid M, Shupliakov O, et al. (2011) A
pericyte origin of spinal cord scar tissue. Science 333: 238–242.
72. Keating A (2012) Mesenchymal stromal cells: new directions. Cell Stem Cell 10:
709–716.
73. Wang S, Qu X, Zhao RC (2012) Clinical applications of mesenchymal stem
cells. J. Hematol. Oncol. 5: 19.
Transcriptome Changes in SCI by MSC or OEC Graft
PLOS ONE | www.plosone.org 13 October 2013 | Volume 8 | Issue 10 | e76141
74. Kwak EK, Kim JW, Kang KS, Lee YH, Hua QH, et al. (2005) The role of
inducible nitric oxide synthase following spinal cord injury in rat. J. Kor. Med.
Sci. 20: 663–669.
75. Lo´pez-Vales R, Garcı´a-Alı´as G, Guzma´n-Lenis MS, Fore´s J, Casas C, et al.
(2006) Effects of COX-2 and iNOS inhibitors alone or in combination with
olfactory ensheathing cell grafts after spinal cord injury. Spine 31: 1100–1106.
76. Lu P, Yang H, Culbertson M, Graham L, Roskams AJ, et al. (2006) Olfactory
ensheathing cells do not exhibit unique migratory or axonal growth-promoting
properties after spinal cord injury. J. Neurosci. 26: 11120–11130.
77. Ruitenberg M, Plant G, Christensen C, Blits B, Niclou S, et al. (2002) Viral
vector-mediated gene expression in olfactory ensheathing glia implants in the
lesioned rat spinal cord. Gene Therapy 9: 135–146.
78. Dressel R, Walter L, Gu¨nther E (2001) Genomic and funtional aspects of the rat
MHC, the RT1 complex. Immunol. Rev. 184: 82–95.
79. Gu¨nther E, Walter L (2001) The major histocompatibility complex of the rat
(Rattus norvegicus). Immunogenicity 53: 520–542.
80. Cole DK, Laugel B, Clement M, Price DA, Wooldridge L, et al. (2012) The
molecular determinants of CD8 co-receptor function. Immunology 137: 139–
148.
81. Heath WR and Carbone FR (2001) Cross-presentation, dendritic cells, tolerance
and immunity. Annu. Rev. Immunol. 19: 47–64.
82. Holling TM, Schooten E, Van Den Elsen PJ (2004) Function and regulation of
MHC class II molecules in T-lymphocytes: of mice and men. Human Immunol.
65: 282–290.
83. Mu¨ller M, Carter S, Hofer MJ, Campbell IL (2010) Review: The chemokine
receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in
neuroimmunity–a tale of conflict and conundrum. Neuropathol. Appl.
Neurobiol. 36: 368–387.
84. Oo YH, Shetty S, Adams DH (2010) The role of chemokines in the recruitment
of lymphocytes to the liver. Digest. Dis. 28: 31–44.
85. Rot A, Von Andrian UH (2004) Chemokines in innate and adaptive host
defense: basic chemokinese grammar for immune cells. Ann. Rev. Immunol. 22:
891–928.
86. Swanger S, Neuhuber B, Himes B, Bakshi A, Fischer I (2005) Analysis of
allogeneic and syngeneic bone marrow stromal cell graft survival in the spinal
cord. Cell Transplant. 10: 775–786.
87. Ronsyn MW, Daans J, Spaepen G, Chatterjee S, Vermeulen K, et al. (2007)
Plasmid-based genetic modification of human bone marrow-derived stromal
cells?: analysis of cell survival and transgene expression after transplantation in
rat spinal cord. BMC Biotech. 17: 1–17.
88. Nandoe Tewarie RDS, Hurtado A, Ritfeld GJ, Rahiem ST, Wendell DF, et al.
(2009) Bone marrow stromal cells elicit tissue sparing after acute but not delayed
transplantation into the contused adult rat thoracic spinal cord. J. Neurotrauma
26: 2313–2322.
89. Jung DI, Ha J, Kang BT, Kim JW, Quan FS, et al. (2009) A comparison of
autologous and allogenic bone marrow-derived mesenchymal stem cell
transplantation in canine spinal cord injury. J. Neurol. Sci. 285: 67–77.
Transcriptome Changes in SCI by MSC or OEC Graft
PLOS ONE | www.plosone.org 14 October 2013 | Volume 8 | Issue 10 | e76141
